Daniel Harrison, MD
PeerA Vision for Change: Exploring Biosimilars in Retinal Disease Management
An Overview of MS Biomarkers
A Review of Biosimilars in Retina
Key Insights on Visit Adherence in Glaucoma Patients
Impacts on Access to Eye Care: Key Socioeconomic Factors
Extended Dosing Intervals in Patients with Wet AMD and DME
Treating Wet AMD: A Look at Anatomic Outcomes
A Treatment Option for Wet AMD and DME
Inherited Retinal Diseases, Genetic Testing, and What Eye Care Professionals Can Do Today